Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Novartis Pharmaceuticals Corporation.
Novartis Pharmaceuticals Corporation: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Novartis Pharmaceuticals Corporation — Warning letters0
Philips North America — Warning letters0
Novartis Pharmaceuticals Corporation — Recalls1
Philips North America — Recalls355
Novartis Pharmaceuticals Corporation — Approval records0
Philips North America — Approval records0
Novartis Pharmaceuticals Corporation — Form 483s0
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Novartis Pharmaceuticals Corporation vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/novartis-pharmaceuticals-corporation-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗